Understanding the Long-Term Effects of SSRIs: Weighing Benefits, Risks, and Alternatives
Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed medications for depression, anxiety, and related conditions. Millions of people worldwide have found relief through these medications, often with minimal side effects. However, like any medical intervention, SSRIs come with both benefits and risks—especially when used long-term.
As with other treatments, individual response to SSRIs varies, and while most patients tolerate them well, some may experience side effects that persist or emerge over time. Understanding these risks—based on recent research—can help individuals and clinicians make informed, balanced decisions.
What Does the Research Say About Long-Term SSRI Use?
Recent large-scale studies and systematic reviews have shed more light on what we can expect from SSRIs over years—not just weeks or months—of use. Here's what the evidence suggests:
The Benefits
SSRIs remain life-changing and even life-saving for many. They are effective in treating moderate to severe depression and anxiety, and they can reduce relapse risk when continued beyond the acute phase. Some studies have also shown protective health effects, such as:
Reduced risk of type 2 diabetes with long-term SSRI use (Hazard Ratio [HR] ~0.64–0.68)
Lower incidence of hypertension over 5–10 years of treatment (HR ~0.77)
These benefits can make a significant difference in long-term quality of life, especially for patients whose mental health challenges previously interfered with daily functioning.
What About the Risks?
It’s important to recognize potential long-term risks, even if they are relatively uncommon or only affect a subset of users. Here are some findings from the most cited research papers on the subject:
1. Cardiovascular and Mortality Risks
A 10-year study from the UK Biobank found a slight increase in cardiovascular mortality (HR ~1.87) and all-cause mortality (HR ~1.73) among long-term SSRI users. While this is notable, researchers caution that some of the effect may be due to underlying mental health conditions themselves, rather than the medication alone.
2. Bone Health and Fracture Risk
SSRIs have been associated with increased risk of osteoporotic fractures (Relative Risk ~1.67), especially in older adults and those on treatment for many years.
3. Persistent Sexual Side Effects (PSSD)
Some users report persistent sexual dysfunction (e.g. low libido, delayed orgasm, erectile dysfunction) even after stopping the medication. Though this appears to affect only a small percentage (estimated ~4% at high risk), it can be deeply distressing when it occurs.
4. Cognitive Impairment and Emotional Blunting
In studies of patients on SSRIs for six months or more:
Over 20% reported cognitive symptoms like reduced attention, motivation, and memory.
Others described emotional blunting, where they felt “numb” or unable to experience the full range of emotions—positive or negative.
5. Withdrawal and Discontinuation Symptoms
Nearly 43% of patients experience withdrawal symptoms such as dizziness, irritability, or “brain zaps” when stopping SSRIs, particularly if stopped abruptly or after prolonged use. These are more common with medications like paroxetine and venlafaxine.
Balancing Risks and Benefits: What You Should Know
All medical treatments—from blood pressure medications to chemotherapy—require a balance of potential benefits and side effects. SSRIs are no exception.
It’s vital to understand that:
Most people tolerate SSRIs well, even over long periods.
For those who do experience side effects, they are often manageable or reversible.
There are many alternatives, both pharmacological (e.g., SNRIs, bupropion, psychotherapy-enhancing meds) and non-pharmacological (CBT, lifestyle interventions, TMS, ketamine, etc.).
If you or a loved one is on an SSRI and concerned about side effects, don’t panic—talk to your provider. In many cases, adjusting the dose, switching medications, or integrating therapy can significantly improve the experience without sacrificing symptom relief.
Final Thoughts
The evolving science around SSRIs reinforces a key principle of good medicine: personalized, informed care. No treatment is one-size-fits-all. Long-term use of SSRIs is beneficial and safe for many, but for others, it may require re-evaluation or adaptation over time.
Whether you're just starting treatment or have been on an SSRI for years, keep the conversation open with your healthcare provider. Together, you can weigh the evidence, monitor your progress, and ensure that your mental health plan serves you best.
Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or prescribing clinician regarding any concerns about medication.
References
Coupland, C., et al. (2022).
Antidepressant use and risk of cardiovascular outcomes and all-cause mortality: A population-based cohort study using UK primary care data.
BMJ, 378:e071171.
https://doi.org/10.1136/bmj-2022-071171Delgado, M.G., et al. (2019).
Adverse effects of antidepressants: An umbrella review of evidence from systematic reviews and meta-analyses of observational studies.
Journal of Affective Disorders, 245, 170–182.
https://doi.org/10.1016/j.jad.2018.10.030Farnsworth, S., & Siskind, D. (2020).
Post-SSRI Sexual Dysfunction: A Review of Current Literature.
The Australian and New Zealand Journal of Psychiatry, 54(1), 4–14.
https://doi.org/10.1177/0004867419879371Read, J., Cartwright, C., & Gibson, K. (2018).
How many of 1829 antidepressant users report withdrawal symptoms or addiction?
Addictive Behaviors, 88, 123–129.
https://doi.org/10.1016/j.addbeh.2018.08.027Fava, G.A., & Offidani, E. (2011).
The mechanisms of tolerance in antidepressant action.
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(7), 1593–1602.
https://doi.org/10.1016/j.pnpbp.2010.07.018Cosci, F., & Chouinard, G. (2020).
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Antidepressants: Recognition and Management.
CNS Drugs, 34(10), 1015–1029.
https://doi.org/10.1007/s40263-020-00717-7Baldwin, D.S., & Foong, T. (2013).
Antidepressant discontinuation symptoms: Phenomenology and management.
CNS Drugs, 27(6), 403–417.
https://doi.org/10.1007/s40263-013-0064-3Price, J., Cole, V., & Goodwin, G.M. (2009).
Emotional side-effects of selective serotonin reuptake inhibitors: Qualitative study.
British Journal of Psychiatry, 195(3), 211–217.
https://doi.org/10.1192/bjp.bp.108.051110Al-Khateeb, H., et al. (2022).
SSRIs and bone health: A review of literature.
International Journal of Geriatric Psychiatry, 37(4), gnp.5634.
https://doi.org/10.1002/gps.5634
